9 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18563354 | MACHINE LEARNING METHODS TO PREDICT MENOPAUSE SYMPTOMS AND TREATMENT OPTIONS | FORRISTALL, JOSHUA L | 2857 | Non-Final OA | Nov 21, 2023 |
| 18283485 | ELECTROCARDIOGRAM ANALYSIS ASSISTANCE DEVICE, PROGRAM, ELECTROCARDIOGRAM ANALYSIS ASSISTANCE METHOD, ELECTROCARDIOGRAM ANALYSIS ASSISTANCE SYSTEM, PEAK ESTIMATION MODEL GENERATION METHOD, AND SEGMENT ESTIMATION MODEL GENERATION METHOD | TEJANI, ANKIT D | 3796 | Non-Final OA | Sep 22, 2023 |
| 18279103 | Methods of Reducing Risk of Prostate Cancer Progression | OH, TAYLOR V | 1625 | Non-Final OA | Aug 28, 2023 |
| 18272020 | MULTISPECIFIC ANTIBODY BINDING TO ActRIIA, ActRIIB, AND Fn14 | LEE, YIE CHIA | 1642 | Non-Final OA | Jul 12, 2023 |
| 18041245 | COMBINATION THERAPY | GAUGER, PAUL RANDALL | 1629 | Non-Final OA | Feb 10, 2023 |
| 17802544 | WEARABLE DEVICE, INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING SYSTEM, AND PROGRAM | COX, THADDEUS B | 3791 | Non-Final OA | Aug 26, 2022 |
| 17783591 | ANTISENSE GUIDE RNA WITH ADDED FUNCTIONAL REGION FOR EDITING TARGET RNA | TRAN, CHRISTINA L | 1637 | Non-Final OA | Jun 08, 2022 |
| 17632157 | COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF CANCER | NATARAJAN, MEERA | 1643 | Final Rejection | Feb 01, 2022 |
| 17079326 | CLAUDIN-18 AS A DIAGNOSTIC AND THERAPEUTIC CANCER TARGET | DENT, ALANA HARRIS | 1643 | Non-Final OA | Oct 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial